F
Fulcrum Therapeutics
FULC
9.01000
USD
-0.27
(-2.91%)
مفتوح الان
حجم التداول
7,914
الربح لكل سهم
0
العائد الربحي
0
P/E
-10
حجم السوق
214,970,653
العنوان: Fulcrum Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.